Archives

  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • EDC.HCl: Technical Use in Peptide, Bioconjugation & Nucleoti

    2026-05-11

    EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride): Technical Guidance for In Vitro Synthesis

    What This Product Solves

    EDC.HCl (CAS 25952-53-8) is a water-soluble carbodiimide reagent optimized for activating carboxyl groups to facilitate amide bond formation in aqueous environments. This reagent addresses the need for a rapid, efficient, and water-compatible coupling agent in peptide synthesis, bioconjugation, and nucleotide synthesis workflows, where traditional carbodiimides may have limited solubility or introduce unwanted side reactions. By forming an activated intermediate with carboxyl groups, EDC.HCl enables straightforward conjugation to primary amines, yielding stable amide bonds and a urea byproduct that is easily separated from reaction mixtures. It is especially valuable in protocols requiring precise control of reaction conditions and compatibility with biological buffers (product_spec).

    EDC.HCl should not be used in in vivo or clinical applications, as there are no supporting data to validate safety or efficacy in those settings (internal_article).

    Protocol Parameters

    • solubility in water | ≥39 mg/mL | preparation of stock solutions for in vitro reactions | Ensures sufficient reagent concentration for peptide synthesis and bioconjugation protocols; allows for rapid dissolution in aqueous buffers | product_spec
    • solubility in DMSO | ≥19.2 mg/mL | for reactions incompatible with water or requiring organic co-solvents | Supports workflows where substrates have limited aqueous solubility | product_spec
    • storage temperature (solid) | -20°C, desiccated | long-term storage of reagent powder | Maintains reagent stability and prevents hydrolysis or decomposition | product_spec
    • solution storage | avoid long-term storage | all in vitro protocols | EDC.HCl solutions degrade over time; prepare fresh before use to maintain reactivity | product_spec
    • quantitation | spectrophotometric monitoring | quality control during reaction setup | Allows for assessment of reagent concentration and degradation in real time | product_spec

    Workflow Setup and QC Checklist

    1. Confirm Reagent Integrity: Use only EDC.HCl stored as a solid at -20°C in a desiccator. Visually inspect for clumping or discoloration before use (product_spec).
    2. Prepare Fresh Solutions: Dissolve EDC.HCl immediately before use. For water-based protocols, use concentrations up to 39 mg/mL; for DMSO, up to 19.2 mg/mL. Discard unused solutions after the reaction to avoid compromised activity.
    3. Buffer Selection: Opt for buffers (e.g., MES, phosphate) that lack competing nucleophilic groups. Avoid buffers containing primary amines, which can consume the EDC.HCl reagent and reduce coupling efficiency (internal_article).
    4. Reaction Monitoring: Employ spectrophotometric or colorimetric methods to verify EDC.HCl consumption and product formation, ensuring reproducibility.
    5. Product Isolation: Remove the urea byproduct via filtration or precipitation, depending on the downstream protocol. This ensures product purity in peptide synthesis or bioconjugation workflows.

    Common Failure Modes and Fixes

    • Incomplete Coupling: May result from degraded EDC.HCl or suboptimal pH. Always prepare fresh solutions and use buffers near neutral pH (typically pH 6-7 for peptide synthesis). Check reagent storage conditions if low yields persist.
    • Hydrolysis of Activated Intermediates: Excess water or prolonged reaction times can lead to side-product formation. Minimize water exposure and process reactions promptly after reagent addition.
    • Buffer Interference: Buffers with primary amines (e.g., Tris) can quench EDC.HCl activity. Substitute with non-nucleophilic buffers such as MES or phosphate to maintain coupling efficiency (internal_article).
    • Overactivation or Side Reactions: Excess EDC.HCl may lead to crosslinking or modification of unintended functional groups. Titrate reagent quantities to match substrate stoichiometry.

    Scope and Limitations

    EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is validated exclusively for in vitro biochemical reactions, including peptide synthesis, bioconjugation, nucleotide synthesis, and esterification protocols. Its water solubility and compatibility with a range of buffers position it as a preferred choice for these workflows. However, its use in in vivo or clinical settings is not supported, and no animal or human studies have been reported (product_spec). Long-term storage of reagent solutions is not recommended due to hydrolytic instability. Additionally, it is not suitable for workflows requiring strictly organic coupling conditions, as hydrolysis risk increases outside recommended solvent systems.

    Conclusion

    EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) provides a technically robust solution for amide bond formation in peptide synthesis, bioconjugation, and nucleotide coupling applications. Adherence to recommended storage, dissolution, and buffer selection protocols is essential for reproducibility and efficiency. For detailed technical applications and troubleshooting, refer to APExBIO's EDC.HCl product page. For further protocol guidance and workflow optimization, see related internal resources such as the Technical Guide and In Vitro Coupling Reagent Guidance, which offer context-specific advice for in vitro applications only.